Only three percent of potential bacterial drug sources known

The emergence of antibiotic-resistant pathogens and the increasing difficulty in developing new drugs has contributed to global challenges in combating infectious diseases. An extensive bioinformatics survey of around 170,000 bacterial genomes indicates that only three percent of the genomic potential for microbial natural products—chemically diverse bacterial metabolites that form the basis of antibiotic drugs—have been discovered so far. Co-led by Prof Nadine Ziemert of the German Center for Infection Research (DZIF), the survey identified several bacterial genera as producers of highly diverse natural products that could help to overcome the bottleneck in drug development.

Quelle: IDW Informationsdienst Wissenschaft